BRPI1013384A2 - peptídeos c6orf167 e vacinas incluindo os mesmos - Google Patents

peptídeos c6orf167 e vacinas incluindo os mesmos

Info

Publication number
BRPI1013384A2
BRPI1013384A2 BRPI1013384A BRPI1013384A BRPI1013384A2 BR PI1013384 A2 BRPI1013384 A2 BR PI1013384A2 BR PI1013384 A BRPI1013384 A BR PI1013384A BR PI1013384 A BRPI1013384 A BR PI1013384A BR PI1013384 A2 BRPI1013384 A2 BR PI1013384A2
Authority
BR
Brazil
Prior art keywords
c6orf167
peptides
same
vaccines including
vaccines
Prior art date
Application number
BRPI1013384A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ohsawa
Sachiko Yoshimura
Takuya Tsunoda
Tomohisa Watanabe
Yataro Daigo
Yusuke Nakamura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of BRPI1013384A2 publication Critical patent/BRPI1013384A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
BRPI1013384A 2009-04-01 2010-03-31 peptídeos c6orf167 e vacinas incluindo os mesmos BRPI1013384A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21170009P 2009-04-01 2009-04-01
PCT/JP2010/002352 WO2010113495A1 (en) 2009-04-01 2010-03-31 C6orf167 peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
BRPI1013384A2 true BRPI1013384A2 (pt) 2016-03-29

Family

ID=42827803

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013384A BRPI1013384A2 (pt) 2009-04-01 2010-03-31 peptídeos c6orf167 e vacinas incluindo os mesmos

Country Status (14)

Country Link
US (1) US20120128705A1 (enExample)
EP (1) EP2414383A4 (enExample)
JP (1) JP5728759B2 (enExample)
KR (1) KR20120034605A (enExample)
CN (2) CN104774260A (enExample)
AU (1) AU2010231381A1 (enExample)
BR (1) BRPI1013384A2 (enExample)
CA (1) CA2757210A1 (enExample)
IL (1) IL215268A0 (enExample)
MX (1) MX2011010191A (enExample)
RU (1) RU2011144088A (enExample)
SG (2) SG174998A1 (enExample)
TW (1) TW201100090A (enExample)
WO (1) WO2010113495A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1907582B1 (en) 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
US8933014B2 (en) 2010-03-11 2015-01-13 Oncotherapy Science, Inc. HJURP peptides and vaccines including the same
WO2012023259A1 (en) * 2010-08-19 2012-02-23 Oncotherapy Science, Inc. C6orf167 as a target gene for cancer therapy and diagnosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003521865A (ja) * 1997-10-24 2003-07-22 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 148個のヒト分泌タンパク質
CN1351069A (zh) * 2000-10-26 2002-05-29 上海博德基因开发有限公司 一种新的多肽——鼠的同ampa受体相互作用的蛋白grip12.54和编码这种多肽的多核苷酸
US7919467B2 (en) * 2000-12-04 2011-04-05 Immunotope, Inc. Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
EP2267023B1 (en) * 2002-09-12 2015-02-11 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Cxadrl1またはgcud1タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
DK2325306T3 (en) * 2005-02-25 2014-03-03 Oncotherapy Science Inc Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP1907582B1 (en) * 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
JP5409658B2 (ja) * 2008-03-13 2014-02-05 セレラ コーポレーション 静脈血栓症に関連した遺伝子多型、その検出方法および使用

Also Published As

Publication number Publication date
JP5728759B2 (ja) 2015-06-03
CN102448980A (zh) 2012-05-09
EP2414383A4 (en) 2013-07-31
CA2757210A1 (en) 2010-10-07
KR20120034605A (ko) 2012-04-12
JP2012522488A (ja) 2012-09-27
SG174998A1 (en) 2011-11-28
RU2011144088A (ru) 2013-05-10
TW201100090A (en) 2011-01-01
EP2414383A1 (en) 2012-02-08
AU2010231381A1 (en) 2011-11-03
MX2011010191A (es) 2011-11-29
SG2014011423A (en) 2014-05-29
CN102448980B (zh) 2015-04-15
IL215268A0 (en) 2011-11-30
US20120128705A1 (en) 2012-05-24
CN104774260A (zh) 2015-07-15
WO2010113495A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
DK2552434T3 (da) Peptider og anvendelse deraf
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
LT3725330T (lt) Stabilūs polipeptidų preparatai ir jų naudojimas
HUE045845T2 (hu) Módosított relaxin polipeptidek és felhasználásuk
BRPI1008061A2 (pt) polipetídeos recombinantes estendidos e composições compreendendo os mesmos
IL225607A0 (en) Heteroaryls and uses thereof
BR112012004731A2 (pt) peptídeos derivados de wnt10 e uso dos mesmos
IL223667B (en) S100a4 antibodies and therapeutic uses thereof
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
EP2318438A4 (en) ANTI-P2X7 PEPTIDES AND EPITOPES
IL229926A (en) Neil3 peptides and vaccines including the same
IL232461A0 (en) Melk epitope peptides and vaccines containing the same
IL228995A0 (en) b5sema peptides and components containing them
BR112013013158A2 (pt) peptídeos de tomm34 e vacinas incluindo os mesmos
BRPI1012312A2 (pt) peptídeos vangl1 e vacinas incluindo os mesmos
BRPI0923938A2 (pt) novos peptideos e uso dos mesmo
BRPI1010666A2 (pt) peptídeos de cdc45l e vacinas incluindo dos mesmos
BRPI1013938A2 (pt) "peptídeos ttk e vacinas incluindo os mesmos"
BRPI0919766A2 (pt) peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo
BRPI0923402A2 (pt) Peptídeos c10rf59 e vacinas incluindo os mesmos.
IL221474A0 (en) Hjurp peptides and vaccines including the same
ZA201207342B (en) Ect2 peptides and vaccines including the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]